Childhood cancer incident and service utilization distribution in TASH, 2018–2019.
收藏数据链接：
官方服务：
资源简介：
Childhood cancer incident and service utilization distribution in TASH, 2018–2019.
应用场景：
创建时间：
2023-06-02
相关数据集
Prevalence and unadjusted prevalence ratios for delay in the initiation of colorectal cancer treatment among diagnosed but untreated individuals, according to individual characteristics and contextual variables. Brazil, by state of residence (n = 41,838).
Prevalence and unadjusted prevalence ratios for delay in the initiation of colorectal cancer treatment among diagnosed but untreated individuals, according to individual characteristics and contextual
NIAID Data Ecosystem10
Share of children's and young adults' cancer cases in total cases Japan 2020, by age
Share of children's and young adults' cancer cases in total cancer cases in Japan in 2020, by age group
Statista00
U.S. rate of new tobacco-associated cancers in 2022, by cancer type
Rate of new tobacco-associated cancers in the United States in 2022, by cancer type (per 100,000 people)
Statista00
Table 3_Global burden of ovarian and uterine cancers attributable to high body-mass index in 204 countries and territories, 1990–2021.xlsx
BackgroundHigh body mass index (BMI) is a well-established risk factor for ovarian and uterine cancer. However, the global, regional, and national burden of these cancers attributable to high BMI rema
NIAID Data Ecosystem00
Supporting information, including S1 Table (Acute respiratory illness diagnosis codes), S2 Table (Counts of patients with comorbidities included in Charlson comorbidity index), S3 Table (Individual characteristics by infecting virus and severity threshold reached); S4 Table (Best-fitting distributions for care utilization pathways for all infections using a 20-day follow-up period); S5 Table (Best-fitting distributions for care utilization pathways at each acuity threshold using a 60-day follow-up period); S6 Tale (Care utilization pathways associated with each infecting virus using a follow-up period of 60 days); S7 Table (Best-fitting distributions for care utilization pathways for all infections using a 60-day follow-up period); S8 Table (Hospital length of stay estimates for admissions leading to discharge or mortality); S9 Table (Proportions of cases attaining or exceeding each acuity threshold, by age); S10 Table (Proportions of cases attaining or exceeding each acuity thresh
Supporting information, including S1 Table (Acute respiratory illness diagnosis codes), S2 Table (Counts of patients with comorbidities included in Charlson comorbidity index), S3 Table (Individual ch
NIAID Data Ecosystem00
